New insulin preparations: A primer for the clinician

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.

Original languageEnglish (US)
Pages (from-to)S27-S33
JournalCleveland Clinic Journal of Medicine
Volume83
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Insulin
Short-Acting Insulin
Diabetes Complications
Pharmacokinetics
Safety
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

New insulin preparations : A primer for the clinician. / Meneghini, Luigi.

In: Cleveland Clinic Journal of Medicine, Vol. 83, No. 5, 01.05.2016, p. S27-S33.

Research output: Contribution to journalReview article

@article{a528d85dd0834c3d80f9ef06bf4825ae,
title = "New insulin preparations: A primer for the clinician",
abstract = "The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.",
author = "Luigi Meneghini",
year = "2016",
month = "5",
day = "1",
doi = "10.3949/ccjm.83.s1.05",
language = "English (US)",
volume = "83",
pages = "S27--S33",
journal = "Cleveland Clinic Journal of Medicine",
issn = "0891-1150",
publisher = "Cleveland Clinic Educational Foundation",
number = "5",

}

TY - JOUR

T1 - New insulin preparations

T2 - A primer for the clinician

AU - Meneghini, Luigi

PY - 2016/5/1

Y1 - 2016/5/1

N2 - The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.

AB - The importance of glycemic control in preventing the chronic and devastating complications of diabetes is well established. Insulin administration is an important therapeutic option for managing diabetes, particularly for patients with profound insulin deficiency. Many insulin formulations are on the market, including short-acting insulin analogues, inhaled insulin, concentrated insulin, and basal insulin. Each category has a unique onset, peak, and duration of action. This article reviews the differing pharmacokinetic and pharmacodynamic properties and safety and efficacy data, and discusses the implications for clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85011541179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011541179&partnerID=8YFLogxK

U2 - 10.3949/ccjm.83.s1.05

DO - 10.3949/ccjm.83.s1.05

M3 - Review article

C2 - 27176680

AN - SCOPUS:85011541179

VL - 83

SP - S27-S33

JO - Cleveland Clinic Journal of Medicine

JF - Cleveland Clinic Journal of Medicine

SN - 0891-1150

IS - 5

ER -